Finding Answers to Your First Questions

When I was diagnosed with breast cancer, I never dreamed I’d learn so many valuable life lessons along the way.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me rediscover my voice as a writer.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.

The FDA granted breakthrough therapy designation to first-line treatment with Enhertu plus Perjeta for unresectable or metastatic HER2+ breast cancer.